Medicine Overview of Romilast L Tablet
Romilast L 2.5 mg/4 mg Tablet is used for sneezing and runny nose due to allergies.
Nausea, Diarrhoea, Vomiting, Dryness in mouth, Headache, Skin rash, Flu-like symptoms, Fatigue, Sleepiness.
Take this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush or break it. Romilast L 2.5 mg/4 mg Tablet may be taken with or without food, but it is better to take it at a fixed time.
Romilast L 2.5 mg/4 mg Tablet is a combination of two medicines: Levocetirizine and Montelukast which treat sneezing and runny nose due to allergies. Levocetirizine is an antiallergic which blocks the action a chemical messenger (histamine) responsible for runny nose, watery eyes and sneezing. Montelukast is a leukotriene antagonist. It works by blocking the action of another chemical messenger (leukotriene). This reduces inflammation (swelling) in the airways and nose, and improves symptoms.
In Depth Information on Romilast L Tablet
Romilast L Tablet related warnings
Romilast L 2.5 mg/4 mg Tablet may cause excessive drowsiness and calmness with alcohol.
Romilast L 2.5 mg/4 mg Tablet is probably safe to use during pregnancy.
Animal studies have shown low or no adverse effect on the foetus, however, there are limited human studies. Please consult your doctor.
Romilast L 2.5 mg/4 mg Tablet is probably safe to use during lactation.
Limited human data suggests that the drug does not represent a significant risk to the baby.
Romilast L 2.5 mg/4 mg Tablet may make you feel dizzy, sleepy, tired, or decrease alertness. If this happens, do not drive.
Romilast L 2.5 mg/4 mg Tablet should be used with caution in patients with kidney disease. Dose adjustment of Romilast L 2.5 mg/4 mg Tablet may be needed. Please consult your doctor.
Use of Romilast L 2.5 mg/4 mg Tablet is not recommended in patients with severe kidney disease.
Romilast L 2.5 mg/4 mg Tablet should be used with caution in patients with severe liver disease. Dose adjustment of Romilast L 2.5 mg/4 mg Tablet may be needed. Please consult your doctor.
Limited information is available on the use of Romilast L 2.5 mg/4 mg Tablet in these patients. No dose adjustment is recommended in patients with mild to moderate liver disease.
No Patient Concerns found for this medicine
User Submitted Feedback For Romilast L 2.5 mg/4 mg Tablet
Patients taking Romilast L 2.5 mg/4 mg Tablet
Survey Participants: 1
“The following are the results of on-going survey on 1mg.com for Romilast L 2.5 mg/4 mg Tablet. These results only indicate the perceptions of the website users. Please base your medical decisions only on the advice of a doctor or a registered medical professional.”
One of the following vendor pharmacies will deliver Romilast L 2.5 mg/4 mg Tablet: HEX, RKS, RDH, RHL, ENP, AAR, DGN, SSA, TFP, WSI, UMP, ATP, HAT, BMJ, RHW, MDH, HGI, DLP, DVH, VNS, HZF, OHM, NVY, SGC, LCC, RJH, NVL, HTS, BHP, RPP, MAK, BHM, HSP, RPI, PMA, ZVP, SCH, GTK, PPR, JIV, DHR, SHC, ATL, P2P, TNH, EMB, MLC, GHR, IAD, PTI, SLN, DFP, RSS, AMR, GTC, PEN, DPL, BAP, NTB, FGH, MPC, ESY, OWP, BLE, SAF, SWA, RDR, NXG, IPL, SYN, PLT, VDH, BDN, PNT, SGH, DYG, RWP, DPP, BSN, ABP, WHL, PWN, JSL, VRS, NSL, RSA, SHD, GBL, BBS, GPP, OIP, OLT, ADT, KHC, USF, AAY, NNH, GPT, KHH, TOM, KMC, 9T9, PRN, BIO, HIP, SDM, SRG, STA, SJP, EVP, QLF, MMS, MAM, LHA, MAX, INC, GNC, ANT, JVN, BAL, THP, HMP, MSD, HPC, PVP, JVO, MDO, HBV, BTM, ARD, RUS, QTM, CLT, HNP, SVH, SBA, TRP, AGT, AYM, SBL, ZEL, EQN, NDP, SWP, SHP, AYU